Glow

BPC-157 + GHK-Cu blend

Rank#999
Skin & HairNot ApprovedAnimalResearchSubQTopical

Popular for:Skin health, tissue repair, cosmetic blend

0

Total Studies

0

Human Studies

Animal

Evidence Level

Not Approved

FDA Status

Overview

"Glow" is a pre-mixed peptide blend combining BPC-157, TB-500, and GHK-Cu in a single vial. It's designed as a synergistic "healing + skin regeneration" stack, combining the tissue repair properties of BPC-157 and TB-500 with the collagen-stimulating and anti-aging effects of GHK-Cu. Sold by multiple vendors including Peptide Sciences, Modern Peptides, and others.

**Originally developed for: **The "Glow" blend is a commercial product, not a clinical compound. It was developed by peptide vendors as a convenience product combining three commonly stacked peptides into one vial for research purposes.

Mechanism of Action

Combines three complementary mechanisms: BPC-157 drives angiogenesis, GI protection, and localized tissue repair via VEGF upregulation. TB-500 promotes cell migration and systemic tissue repair via actin binding. GHK-Cu stimulates collagen/elastin synthesis, provides antioxidant protection, and modulates gene expression toward regenerative pathways. Together, they address healing from multiple angles simultaneously.

Key Research Benefits

Primary Benefits (synergistic combination):

Comprehensive tissue repair — BPC-157 + TB-500 cover both localized and systemic healing pathways
Skin regeneration — GHK-Cu drives collagen, elastin, and glycosaminoglycan production for improved skin quality
Wound healing — All three components promote angiogenesis and cellular repair through complementary mechanisms
Anti-inflammatory — Multiple anti-inflammatory pathways activated simultaneously

Secondary Benefits:

Hair growth support (GHK-Cu + TB-500 both show hair benefits individually)
Gut healing (BPC-157 component)
Anti-aging gene modulation (GHK-Cu component)

Clinical Evidence Summary

Combination Product

Glow is a proprietary blend of GHK-Cu, BPC-157, and TB-500. No clinical studies exist for this specific combination. The research data shown reflects studies of the individual compounds. See each component's page for detailed evidence.

*No clinical research exists on this specific blend combination. Evidence is extrapolated from individual peptide studies.*

- See individual pages for BPC-157, TB-500, and GHK-Cu for component-level research

- The rationale for combining them is based on complementary mechanisms, not clinical validation of the specific blend

Key Studies / PubMed References

Combination Product

Studies below may reference individual compounds, not this specific combination.

Scrub Nurse in the Glow.

Review

Lu Y · The Journal of bone and joint surgery. American volume · 2026

PMID: 41264674

Glow in the dark.

Review

Gupta C, Shree N, Das S · Orbit (Amsterdam, Netherlands) · 2026

PMID: 41734018

Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Review

Palese M, Advani RH, Biney-Amissah D, et al. · Pediatric blood & cancer · 2025

PMID: 40059286

Glow.

Review

Woodworth S · Journal of general internal medicine · 2025

PMID: 40728802

The blue glow of halides.

Review

Zhang X, Jin Y, Gao P · Nature reviews. Chemistry · 2025

PMID: 40050491

Side Effects & Safety

*Side effects are the combined profile of all three components. See individual peptide pages for detailed information.*

Injection site redness/irritation
Mild nausea, lightheadedness, fatigue (uncommon)
Angiogenesis concern — same cancer risk caveat as individual BPC-157 and TB-500

> Key concern with blends: No studies exist on the stability and interaction of these three peptides combined in one vial. Individual stability profiles may differ, and peptides could theoretically degrade or interact differently when mixed. Purchasing individually and mixing at time of injection gives more control.

Known Interactions

No curated interaction entry is live for Glow yet.

Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.

Frequently Asked Questions

Research Disclaimer

This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Glow is not approved by the FDA for human therapeutic use. Always consult a qualified healthcare professional before making any health-related decisions. The studies referenced are linked to their original PubMed sources for verification.